Logo image of TESB.BR

TESSENDERLO GROUP (TESB.BR) Stock Fundamental Analysis

Europe - EBR:TESB - BE0003555639 - Common Stock

25.975 EUR
-0.17 (-0.67%)
Last: 10/31/2025, 5:29:56 PM
Fundamental Rating

4

We assign a fundamental rating of 4 out of 10 to TESB. TESB was compared to 68 industry peers in the Chemicals industry. While TESB seems to be doing ok healthwise, there are quite some concerns on its profitability. TESB has a correct valuation and a medium growth rate.


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

TESB had negative earnings in the past year.
In the past year TESB had a positive cash flow from operations.
In the past 5 years TESB has always been profitable.
In the past 5 years TESB always reported a positive cash flow from operatings.
TESB.BR Yearly Net Income VS EBIT VS OCF VS FCFTESB.BR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M

1.2 Ratios

The Return On Assets of TESB (-0.96%) is worse than 66.18% of its industry peers.
TESB's Return On Equity of -1.52% is on the low side compared to the rest of the industry. TESB is outperformed by 64.71% of its industry peers.
TESB has a Return On Invested Capital (2.47%) which is comparable to the rest of the industry.
Measured over the past 3 years, the Average Return On Invested Capital for TESB is in line with the industry average of 7.01%.
Industry RankSector Rank
ROA -0.96%
ROE -1.52%
ROIC 2.47%
ROA(3y)5.03%
ROA(5y)5.73%
ROE(3y)8.04%
ROE(5y)10.34%
ROIC(3y)6.25%
ROIC(5y)7.52%
TESB.BR Yearly ROA, ROE, ROICTESB.BR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15

1.3 Margins

In the last couple of years the Profit Margin of TESB has declined.
TESB has a Operating Margin (2.61%) which is comparable to the rest of the industry.
In the last couple of years the Operating Margin of TESB has declined.
With a Gross Margin value of 19.33%, TESB is not doing good in the industry: 72.06% of the companies in the same industry are doing better.
In the last couple of years the Gross Margin of TESB has declined.
Industry RankSector Rank
OM 2.61%
PM (TTM) N/A
GM 19.33%
OM growth 3Y-39.29%
OM growth 5Y-20.88%
PM growth 3Y-43.63%
PM growth 5Y-21.76%
GM growth 3Y-9.65%
GM growth 5Y-5.01%
TESB.BR Yearly Profit, Operating, Gross MarginsTESB.BR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15 20 25

6

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), TESB is destroying value.
TESB has less shares outstanding than it did 1 year ago.
TESB has more shares outstanding than it did 5 years ago.
TESB has a worse debt/assets ratio than last year.
TESB.BR Yearly Shares OutstandingTESB.BR Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M
TESB.BR Yearly Total Debt VS Total AssetsTESB.BR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B 2.5B

2.2 Solvency

An Altman-Z score of 2.08 indicates that TESB is not a great score, but indicates only limited risk for bankruptcy at the moment.
TESB's Altman-Z score of 2.08 is in line compared to the rest of the industry. TESB outperforms 42.65% of its industry peers.
TESB has a debt to FCF ratio of 2.34. This is a good value and a sign of high solvency as TESB would need 2.34 years to pay back of all of its debts.
The Debt to FCF ratio of TESB (2.34) is better than 91.18% of its industry peers.
TESB has a Debt/Equity ratio of 0.06. This is a healthy value indicating a solid balance between debt and equity.
TESB has a Debt to Equity ratio of 0.06. This is amongst the best in the industry. TESB outperforms 88.24% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.06
Debt/FCF 2.34
Altman-Z 2.08
ROIC/WACC0.34
WACC7.2%
TESB.BR Yearly LT Debt VS Equity VS FCFTESB.BR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B

2.3 Liquidity

A Current Ratio of 1.94 indicates that TESB should not have too much problems paying its short term obligations.
TESB's Current ratio of 1.94 is fine compared to the rest of the industry. TESB outperforms 64.71% of its industry peers.
A Quick Ratio of 1.18 indicates that TESB should not have too much problems paying its short term obligations.
TESB's Quick ratio of 1.18 is in line compared to the rest of the industry. TESB outperforms 55.88% of its industry peers.
Industry RankSector Rank
Current Ratio 1.94
Quick Ratio 1.18
TESB.BR Yearly Current Assets VS Current LiabilitesTESB.BR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

4

3. Growth

3.1 Past

TESB shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -131.08%.
The earnings per share for TESB have been decreasing by -20.75% on average. This is quite bad
TESB shows a small growth in Revenue. In the last year, the Revenue has grown by 2.05%.
TESB shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 8.72% yearly.
EPS 1Y (TTM)-131.08%
EPS 3Y-45.77%
EPS 5Y-20.75%
EPS Q2Q%-116.23%
Revenue 1Y (TTM)2.05%
Revenue growth 3Y8.35%
Revenue growth 5Y8.72%
Sales Q2Q%7.08%

3.2 Future

The Earnings Per Share is expected to grow by 19.97% on average over the next years. This is quite good.
TESB is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 3.83% yearly.
EPS Next Y26.82%
EPS Next 2Y23.83%
EPS Next 3Y19.97%
EPS Next 5YN/A
Revenue Next Year2.34%
Revenue Next 2Y3.91%
Revenue Next 3Y3.83%
Revenue Next 5YN/A

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
TESB.BR Yearly Revenue VS EstimatesTESB.BR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 1B 2B 3B
TESB.BR Yearly EPS VS EstimatesTESB.BR Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 1 2 3 4 5

5

4. Valuation

4.1 Price/Earnings Ratio

TESB reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
With a Price/Forward Earnings ratio of 14.76, TESB is valued correctly.
Compared to the rest of the industry, the Price/Forward Earnings ratio of TESB indicates a somewhat cheap valuation: TESB is cheaper than 69.12% of the companies listed in the same industry.
When comparing the Price/Forward Earnings ratio of TESB to the average of the S&P500 Index (22.52), we can say TESB is valued slightly cheaper.
Industry RankSector Rank
PE N/A
Fwd PE 14.76
TESB.BR Price Earnings VS Forward Price EarningsTESB.BR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20 -40

4.2 Price Multiples

TESB's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. TESB is cheaper than 91.18% of the companies in the same industry.
TESB's Price/Free Cash Flow ratio is rather cheap when compared to the industry. TESB is cheaper than 83.82% of the companies in the same industry.
Industry RankSector Rank
P/FCF 14.21
EV/EBITDA 5.17
TESB.BR Per share dataTESB.BR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20 30 40

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
TESB's earnings are expected to grow with 19.97% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y23.83%
EPS Next 3Y19.97%

4

5. Dividend

5.1 Amount

TESB has a Yearly Dividend Yield of 1.91%. Purely for dividend investing, there may be better candidates out there.
Compared to an average industry Dividend Yield of 3.10, TESB has a dividend in line with its industry peers.
Compared to an average S&P500 Dividend Yield of 2.35, TESB has a dividend comparable with the average S&P500 company.
Industry RankSector Rank
Dividend Yield 1.91%

5.2 History

On average, the dividend of TESB grows each year by 6.16%, which is quite nice.
Dividend Growth(5Y)6.16%
Div Incr Years0
Div Non Decr Years2
TESB.BR Yearly Dividends per shareTESB.BR Yearly Dividends per shareYearly Dividends per share 2023 2024 2025 0.2 0.4 0.6

5.3 Sustainability

The earnings of TESB are negative and hence is the payout ratio. TESB will probably not be able to sustain this dividend level.
TESB's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP-166.05%
EPS Next 2Y23.83%
EPS Next 3Y19.97%
TESB.BR Yearly Income VS Free CF VS DividendTESB.BR Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M

TESSENDERLO GROUP

EBR:TESB (10/31/2025, 5:29:56 PM)

25.975

-0.17 (-0.67%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryChemicals
Earnings (Last)08-21 2025-08-21
Earnings (Next)03-24 2026-03-24/amc
Inst Owners6.25%
Inst Owner ChangeN/A
Ins Owners67.43%
Ins Owner ChangeN/A
Market Cap1.56B
Revenue(TTM)2.75B
Net Income(TTM)-27100000
Analysts74
Price Target27.8 (7.03%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 1.91%
Yearly Dividend0.88
Dividend Growth(5Y)6.16%
DP-166.05%
Div Incr Years0
Div Non Decr Years2
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0.93%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)-9.13%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)-2.21%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 14.76
P/S 0.57
P/FCF 14.21
P/OCF 5.41
P/B 0.88
P/tB 1.01
EV/EBITDA 5.17
EPS(TTM)-0.45
EYN/A
EPS(NY)1.76
Fwd EY6.77%
FCF(TTM)1.83
FCFY7.04%
OCF(TTM)4.8
OCFY18.47%
SpS45.64
BVpS29.62
TBVpS25.79
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -0.96%
ROE -1.52%
ROCE 3.29%
ROIC 2.47%
ROICexc 2.77%
ROICexgc 3.14%
OM 2.61%
PM (TTM) N/A
GM 19.33%
FCFM 4.01%
ROA(3y)5.03%
ROA(5y)5.73%
ROE(3y)8.04%
ROE(5y)10.34%
ROIC(3y)6.25%
ROIC(5y)7.52%
ROICexc(3y)6.83%
ROICexc(5y)8.71%
ROICexgc(3y)7.61%
ROICexgc(5y)9.79%
ROCE(3y)8.33%
ROCE(5y)10.06%
ROICexgc growth 3Y-43.17%
ROICexgc growth 5Y-19.86%
ROICexc growth 3Y-44.09%
ROICexc growth 5Y-20.16%
OM growth 3Y-39.29%
OM growth 5Y-20.88%
PM growth 3Y-43.63%
PM growth 5Y-21.76%
GM growth 3Y-9.65%
GM growth 5Y-5.01%
F-Score6
Asset Turnover0.97
Health
Industry RankSector Rank
Debt/Equity 0.06
Debt/FCF 2.34
Debt/EBITDA 0.38
Cap/Depr 80.05%
Cap/Sales 6.5%
Interest Coverage 7.18
Cash Conversion 97.86%
Profit Quality N/A
Current Ratio 1.94
Quick Ratio 1.18
Altman-Z 2.08
F-Score6
WACC7.2%
ROIC/WACC0.34
Cap/Depr(3y)86.45%
Cap/Depr(5y)81.94%
Cap/Sales(3y)5.77%
Cap/Sales(5y)5.54%
Profit Quality(3y)143.93%
Profit Quality(5y)139.31%
High Growth Momentum
Growth
EPS 1Y (TTM)-131.08%
EPS 3Y-45.77%
EPS 5Y-20.75%
EPS Q2Q%-116.23%
EPS Next Y26.82%
EPS Next 2Y23.83%
EPS Next 3Y19.97%
EPS Next 5YN/A
Revenue 1Y (TTM)2.05%
Revenue growth 3Y8.35%
Revenue growth 5Y8.72%
Sales Q2Q%7.08%
Revenue Next Year2.34%
Revenue Next 2Y3.91%
Revenue Next 3Y3.83%
Revenue Next 5YN/A
EBIT growth 1Y10.97%
EBIT growth 3Y-34.22%
EBIT growth 5Y-13.98%
EBIT Next Year250.49%
EBIT Next 3Y60.07%
EBIT Next 5YN/A
FCF growth 1Y88.36%
FCF growth 3Y0.11%
FCF growth 5Y5.75%
OCF growth 1Y37.17%
OCF growth 3Y10.33%
OCF growth 5Y8.69%

TESSENDERLO GROUP / TESB.BR FAQ

Can you provide the ChartMill fundamental rating for TESSENDERLO GROUP?

ChartMill assigns a fundamental rating of 4 / 10 to TESB.BR.


What is the valuation status of TESSENDERLO GROUP (TESB.BR) stock?

ChartMill assigns a valuation rating of 5 / 10 to TESSENDERLO GROUP (TESB.BR). This can be considered as Fairly Valued.


Can you provide the profitability details for TESSENDERLO GROUP?

TESSENDERLO GROUP (TESB.BR) has a profitability rating of 3 / 10.


Can you provide the financial health for TESB stock?

The financial health rating of TESSENDERLO GROUP (TESB.BR) is 6 / 10.